TrademarkDir
THE PEER STUDY
DEAD

Serial Number

77710073

Owner

MERITAGE PHARMA, INC.

Attorney

F.T. Alexandra Mahaney

First Use Date

Apr 1, 2009

Filing Date

Apr 8, 2009

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

THE PEER STUDY Trademark

Serial Number: 77710073 • Registration: 3866027

THE PEER STUDY is a trademark filed by MERITAGE PHARMA, INC. on April 8, 2009. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

MERITAGE PHARMA, INC. (2 trademarks)

12671 High Bluff Drive, Suite 200
San Diego, CA 92130

Entity Type: 03

Trademark Details

Filing Date

April 8, 2009

Registration Date

October 19, 2010

First Use Anywhere

April 1, 2009

First Use in Commerce

April 1, 2009

Cancellation Date

May 26, 2017

Goods & Services

Providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Filing History

CANCELLED SEC. 8 (6-YR)
May 26, 2017 C8..
REGISTERED-SUPPLEMENTAL REGISTER
Oct 19, 2010 R.SR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 15, 2010 PREV
ASSIGNED TO LIE
Sep 14, 2010 ALIE
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Sep 2, 2010 CNTA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 13, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 12, 2010 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 12, 2010 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 16, 2010 GNFN
FINAL REFUSAL E-MAILED
Feb 16, 2010 GNFR
FINAL REFUSAL WRITTEN
Feb 16, 2010 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 6, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 6, 2010 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 6, 2010 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 6, 2009 GNRN
NON-FINAL ACTION E-MAILED
Jul 6, 2009 GNRT
NON-FINAL ACTION WRITTEN
Jul 6, 2009 CNRT
ASSIGNED TO EXAMINER
Jun 25, 2009 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 13, 2009 NWOS
NEW APPLICATION ENTERED
Apr 11, 2009 NWAP

Related Trademarks

More from this Owner

MERITAGE PHARMA

MERITAGE PHARMA